Pharmafile Logo

clarkhealthcommunications

- PMLiVE

GSK’s RSV vaccine Arexvy approved by FDA for use in adults aged 50 to 59 years

The decision comes just over a year after the FDA approved Arexvy for use in adults aged 60 years and older

- PMLiVE

Tiziana shares promising results for intranasal foralumab in secondary progressive MS

The neurological disease is estimated to affect 2.8 million people globally

- PMLiVE

FDA approves Geron’s Rytelo to treat lower-risk myelodysplastic syndrome patients

The oligonucleotide telomerase inhibitor is administered as an intravenous infusion every four weeks

- PMLiVE

BMS shares positive phase 3 results for Opdivo/Yervoy combination in liver cancer

Hepatocellular carcinoma accounts for 90% of all liver cancer cases and is often diagnosed at an advanced stage

- PMLiVE

GSK enhances oligonucleotide capabilities with $50m Elsie acquisition

The ability of oligonucleotides to modulate gene expression makes them an attractive modality for drugmakers

- PMLiVE

PM Society Digital Awards – tickets now on sale!

The ceremony will take place on 12 September 2024 at The Brewery in London

- PMLiVE

Stemming the Flow–Medscape Presents at HLTH Europe

Medscape Education will be attending HLTH Europe from June 17-20. Be sure to drop by our booth to participate in our survey and enjoy exciting giveaways. Additionally, Dr. John Whyte,...

Medscape Education Global

Boosting Engagement with Expert Moderators – Impetus InSite Tips #8

Boost interactivity in your virtual sessions with a skilled moderator! Our latest tip shows how expert moderation keeps discussions lively and ensures every voice is heard. See the difference a...

Impetus Digital

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links